These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 22309460)
1. Cortical morphometry in narcolepsy with cataplexy. Schaer M; Poryazova R; Schwartz S; Bassetti CL; Baumann CR J Sleep Res; 2012 Oct; 21(5):487-94. PubMed ID: 22309460 [TBL] [Abstract][Full Text] [Related]
2. Voxel-based morphometry in hypocretin-deficient narcolepsy. Overeem S; Steens SC; Good CD; Ferrari MD; Mignot E; Frackowiak RS; van Buchem MA; Lammers GJ Sleep; 2003 Feb; 26(1):44-6. PubMed ID: 12627731 [TBL] [Abstract][Full Text] [Related]
3. Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation. Grimaldi D; Agati P; Pierangeli G; Franceschini C; Guaraldi P; Barletta G; Vandi S; Cevoli S; Plazzi G; Montagna P; Cortelli P Chronobiol Int; 2010 Sep; 27(8):1596-608. PubMed ID: 20854137 [TBL] [Abstract][Full Text] [Related]
4. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Nishino S; Kanbayashi T Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155 [TBL] [Abstract][Full Text] [Related]
5. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency. Knudsen S; Gammeltoft S; Jennum PJ Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934 [TBL] [Abstract][Full Text] [Related]
6. Reduced hypothalamic gray matter in narcolepsy with cataplexy. Buskova J; Vaneckova M; Sonka K; Seidl Z; Nevsimalova S Neuro Endocrinol Lett; 2006 Dec; 27(6):769-72. PubMed ID: 17187022 [TBL] [Abstract][Full Text] [Related]
7. Narcolepsy with cataplexy and comorbid immunopathological diseases. Martínez-Orozco FJ; Vicario JL; Villalibre-Valderrey I; De Andrés C; Fernández-Arquero M; Peraita-Adrados R J Sleep Res; 2014 Aug; 23(4):414-9. PubMed ID: 24645699 [TBL] [Abstract][Full Text] [Related]
8. Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels. Nakamura M; Kanbayashi T; Sugiura T; Inoue Y J Sleep Res; 2011 Mar; 20(1 Pt 1):45-9. PubMed ID: 20642748 [TBL] [Abstract][Full Text] [Related]
9. High-amplitude theta wave bursts during REM sleep and cataplexy in hypocretin-deficient narcoleptic mice. Bastianini S; Silvani A; Berteotti C; Lo Martire V; Zoccoli G J Sleep Res; 2012 Apr; 21(2):185-8. PubMed ID: 21883592 [TBL] [Abstract][Full Text] [Related]
11. The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency. Overeem S; van Nues SJ; van der Zande WL; Donjacour CE; van Mierlo P; Lammers GJ Sleep Med; 2011 Jan; 12(1):12-8. PubMed ID: 21145280 [TBL] [Abstract][Full Text] [Related]
12. Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness? Wienecke M; Werth E; Poryazova R; Baumann-Vogel H; Bassetti CL; Weller M; Waldvogel D; Storch A; Baumann CR J Sleep Res; 2012 Dec; 21(6):710-7. PubMed ID: 22747735 [TBL] [Abstract][Full Text] [Related]
13. The clinical spectrum of narcolepsy with cataplexy: a reappraisal. Sturzenegger C; Bassetti CL J Sleep Res; 2004 Dec; 13(4):395-406. PubMed ID: 15560774 [TBL] [Abstract][Full Text] [Related]
14. Sleepiness that cannot be overcome: narcolepsy and cataplexy. Han F Respirology; 2012 Nov; 17(8):1157-65. PubMed ID: 22471619 [TBL] [Abstract][Full Text] [Related]
15. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy. Weinhold SL; Seeck-Hirschner M; Nowak A; Hallschmid M; Göder R; Baier PC Behav Brain Res; 2014 Apr; 262():8-13. PubMed ID: 24406723 [TBL] [Abstract][Full Text] [Related]
16. Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal Orexin A (Hypocretin-1). Baier PC; Weinhold SL; Huth V; Gottwald B; Ferstl R; Hinze-Selch D Brain; 2008 Oct; 131(Pt 10):2734-41. PubMed ID: 18718966 [TBL] [Abstract][Full Text] [Related]
17. Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study. Luca G; Haba-Rubio J; Dauvilliers Y; Lammers GJ; Overeem S; Donjacour CE; Mayer G; Javidi S; Iranzo A; Santamaria J; Peraita-Adrados R; Hor H; Kutalik Z; Plazzi G; Poli F; Pizza F; Arnulf I; Lecendreux M; Bassetti C; Mathis J; Heinzer R; Jennum P; Knudsen S; Geisler P; Wierzbicka A; Feketeova E; Pfister C; Khatami R; Baumann C; Tafti M; J Sleep Res; 2013 Oct; 22(5):482-95. PubMed ID: 23496005 [TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy. Heier MS; Jansson TS; Gautvik KM J Clin Sleep Med; 2011 Dec; 7(6):653-8. PubMed ID: 22171205 [TBL] [Abstract][Full Text] [Related]
19. Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy. Overeem S; Scammell TE; Lammers GJ Curr Opin Neurol; 2002 Dec; 15(6):739-45. PubMed ID: 12447114 [TBL] [Abstract][Full Text] [Related]
20. Lower wake resting sympathetic and cardiovascular activities in narcolepsy with cataplexy. Donadio V; Liguori R; Vandi S; Pizza F; Dauvilliers Y; Leta V; Giannoccaro MP; Baruzzi A; Plazzi G Neurology; 2014 Sep; 83(12):1080-6. PubMed ID: 25098533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]